Purespring to present three posters at the American Society of Nephrology Kidney Week 2025
New information to be presented on the study design and methodology of Purespring's Phase I/II trial of PS-002, an AAV-based therapy delivering the complement factor I to podocytes in patients with IgA nephropathy Patient and carer feedback from insights sessions on gene therapy study concepts in nephrology will be presented Purespring co-author paper with real […]